The Wall Street Journal: Rudy Giuliani, Pam Bondi, Alex Azar among candidates to replace Jeff Sessions as attorney general [MarketWatch]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MarketWatch
Rudy Giuliani, Pam Bondi, Alex Azar among candidates to replace Jeff Sessions as attorney general President Trump has been talking to advisers for months about a potential replacement for Attorney General Jeff Sessions, who was forced out Wednesday. Here are some of the leading candidates Trump is considering, based on interviews with his advisers and people close to the White House. Alex Azar has served as Health and Human Services secretary since January. He previously served as general counsel for that agency in former President George W. Bush’s administration, then headed an affiliate of pharmaceutical maker Eli Lilly & Co. LLY, +0.55% before returning to Washington. A person familiar with his thinking told The Wall Street Journal last month that Azar wasn’t interested in the top job at the Justice Department. An expanded version of this article appears at WSJ.com . Popular on WSJ.com: Sessions pushed out as attorney general Kemp says he won Georgia governor’s race, but Ab
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Micro-Cap Avalo Therapeutics Stock Rallies As It Snaps AlmataBio For Ex-Eli Lilly Drug For Skin Disorder [Yahoo! Finance]Yahoo! Finance
- DoH Collaborates with Eli Lilly and World Obesity Federation on Obesity Prevention and Management [Yahoo! Finance]Yahoo! Finance
- Global CAR-T Cell Therapy Market Expected to Surge to USD 34.04 Billion by 2034 with a CAGR of 23.33% [Yahoo! Finance]Yahoo! Finance
- Altimmune Obesity Drug Sheds Fat With Less Muscle Loss in Trial [BNN Bloomberg (Canada)]BNN Bloomberg
- Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/6/24 - Miss
LLY
Sec Filings
- 3/28/24 - Form PX14A6G
- 3/28/24 - Form PX14A6G
- 3/22/24 - Form DEFA14A
- LLY's page on the SEC website